There have been many COVID driven impacts on customer engagement and marketing processes, tools, and tactics. However, even with the advancement of digital marketing and commercial transformation, in-person engagement still remains the cornerstone of the pharma marketing business. While we should celebrate the small wins and pivots that have been made as a result of COVID forced change, it is vital to understand which of these changes are transitory and which are true, long lasting transformations and innovation to be built on, and embedded in future processes and planning. What will be our indicators and measurements of value moving forward? What are the content consumption habits/behaviors of HCPs now? How can I de-risk from supply chain to product development to commercial activity? How can I diversify our clinical trial recruitment and innovation? Does reimbursement need to be integrated with innovation? How can I effectively virtualize customer engagement, branding and product launches? What is the right promotional mix, even if/when sales force can return? To what extent are the different stakeholder activities changing/overlapping as business needs evolve? These are just a fraction of the issues currently creating bottlenecks that require proactive future planning and careful roadmap development. Join our expert speaker faculty, the Thought Leadership Council and many of your industry peers to develop this roadmap together as a true community.

1. Roadmap For Embedding Long Term Commercial Evolution in Marketing
#reimaginepharma
MEDIA PARTNERS:
TOP REASONS TO ATTEND:
Amplify digital at a critical time – identifying what the triggers for ‘must do’ changes, and assessing if these are these connected to true long
lasting digital transformation
Examining COVID forced acceptance of omnichannel marketing importance: where do CX and MCM groups need to channel their energy and what
elements to prioritize to deliver a consistent experience of your brand
Analyze content consumption habits and behaviors of HCPs to develop your content and engagement strategy
Scaling video content – keeping the authenticity; examples of good stories that make for great content and pull the story forward to capture
emotion
Quantify the right promotional mix to select the right channel for the corresponding campaign
Optimize your patient journey and adherence as a marketing aid – how ‘how to’ and ‘why’ build as patients continue to increase levels of
expectation on access and reach
Build a successful performance measurement framework to better interpret your data and understand your goals within analytics
Minimize data noise and digital health errors through smart use of data analytics and combining data sources
Reimbursement: relocating reimbursement as part of the innovation process – understand the value proposition of tech and quantify the
willingness to pay
Evaluate if we have seen the promise of AI come to fruition in this current period of turbulence. Has it done the job that we thought it would?
Develop a methodology of how to split personal and non-personal promotion
November 9-10, 2020 | Virtual Summit
Shwen Gwee
Vice President and Head of
Global Digital Strategy
BRISTOL-MYERS SQUIBB
Francesca Wuttke
Chief Digital Officer
ALMIRALL
Dan Gandor
Director, US Customer Experience,
Oncology and Virology
ABBVIE
Matt Lasmanis
Chief Technology Officer
and Vice President
GLAXOSMITHKLINE
Melissa Saw
Director - Marketing
Procurement
BAYER
https://cvent.me/xqEv2r
https://momentumevents.com/re-imaginepharma/
James Musick
Senior Vice President,
Global Product Strategy Head,
Personalized Healthcare
GENENTECH/ROCHE
Kate Innelli
Director, Digital Health
and Innovation
AMGEN
Kevin Hsieh
Service Lead, Web and Mobile
GENENTECH
Michael Rowbotham
Digital Strategy Lead for Xeljanz
Franchise, Director MCM
PFIZER
Alison Woo
Head of Content and Editorial,
Scientific Communications
and Innovation
GLAXOSMITHKLINE
Igor Rudychev
Head of Commercial Analytics
NOVARTIS
Jessica Pfennig
Enterprise Digital Leader,
Compliance Business Partner,
Commercial Operations NA and
Oncology Business Unit
ASTRAZENECA
Lisa Flaiz
Director MCM, Worldwide Digital
Hub Lead for Consumer Marketing
BRISTOL-MYERS SQUIBB
Paul Savidge
US General Counsel
SPARK THERAPEUTICS
SPONSORS:
www.re-imaginepharma.com

2. VIRTUAL SUMMIT
Speakers will be available for Q&A and further dialogue within their respective
‘Meet The Speaker’ Break Out Pods:
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated
VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not
a live chat or faceless group. This is an opportunity to have an engaged conversation
with your industry counterparts. The speaker may have questions for you!
Request 1:1 peer meetings, with video and voice call capabilities to replicate the live event
onsite experience of sharing challenges, solutions and partner evaluations
Visit Virtual Booths and have live video demonstrations/voice calls of pivot solutions to navigate
the current uncertainty
Simply exchange thoughts with your peers in the live chat
Driving Meaningful Change in Diversity in Clinical Trial Recruitment as Part
of a Long Term Business Transformation
Business and Commercial Transformation Priorities at a Time of Turbulence
for Customer Engagement
Examining Omnichannel Marketing Importance: Where do CX and
MCM/Omnichannel Teams Need to Prioritize to Deliver a Consistent Experience
and Customer Engagement
Panelists:
Interactive live polling available to interact with both the experts and attendees!
Digital Transformation as Part of the Evolving Bayer Experience
Day 1 - November 9, 2020
November 9-10, 2020
Shwen Gwee
Vice President and Head of
Global Digital Strategy
BRISTOL-MYERS SQUIBB
Zoe Dunn
Principal
HALE ADVISORS
Bob Allen
Lead, Digital Operations and
Global Public Affairs
BRISTOL-MYERS SQUIBB
Matt Lasmanis
Chief Technology Officer
and Vice President
GLAXOSMITHKLINE
Hans Kaspersetz
CEO
ARTERIC
Melissa Saw
Director - Marketing Procurement
BAYER
Dan Gandor
Director, US Customer Experience,
Oncology and Virology
ABBVIE
John Lineen
Director, Digital Engagement Lead
(CV/IM), Worldwide Engagement
Planning and Content Capabilities
BRISTOL-MYERS SQUIBB
Lisa Flaiz
Director MCM, Worldwide Digital
Hub Lead for Consumer Marketing
BRISTOL-MYERS SQUIBB
Janos Penzes
International eMarketing Manager,
Digital Center of Excellence Lead
RICHTER GEDEON
Zoe Dunn
Principal
HALE ADVISORS
•
•
•
Shirley Whitfield
Senior Director, Global Digital
Planning MLR Transformation
ASTRAZENECA
Bob Allen
Lead, Digital Operations and
Global Public Affairs
BRISTOL-MYERS SQUIBB
Matt Lasmanis
Chief Technology Officer and
Vice President
GLAXOSMITHKLINE
Melissa Saw
Director - Marketing Procurement
BAYER
#reimaginepharmahttps://cvent.me/xqEv2r
https://momentumevents.com/re-imaginepharma/
Paul Murasko
Senior Director,
Digital Interaction
IPSEN PHARMACEUTICALS
9:50 am
Co-Chairs Welcome Address
9:45 am
Opening Address from Momentum Health
10:00 am
Keynote Plenary Presentation
10:20 am
Keynote Plenary Presentation
10:40 am
Session Outline To Be Determined
11:00 am
Keynote Plenary Presentation
11:20 am
Meet the Speaker Pods
11:40 am
Omnichannel for Marketers
12:00 am
INTERACTIVE ROUNDTABLE
Networking Break
Hans Kaspersetz
CEO
ARTERIC

3. VIRTUAL SUMMIT
Working at The Intersection of MedTech and Digital Health: The Business Case
and Value Proposition For Innovative Technologies
November 9-10, 2020
How to Commercialize and Successfully Execute a Virtual Product Launch:
A Rapid COVID-19 Diagnostic Platform
Using Digital Health to Improve Access to Care During Covid-19 and Beyond
Scaling Video Content - Keeping the Authenticity; Examples of Good Stories
That Make For Great Content and Pull the Story Forward to Capture Emotion
The Man on the Moon, Old Guys with Cigars and The New Digital Creative
Amanda Phraner
Director, Public Relations and Social Media
HORIZON THERAPEUTICS
Jim Delash
Multichannel Marketing Director
GLAXOSMITHKLINE
Stephen Ranjan
Vice President, Franchise Lead Professional
and Non-Insulin Therapy Solutions, Strategy
and Customer Solutions
ROCHE DIABETES CARE
Continue the Q&A and face to face dialogue for as long as your schedule will allow.
We do not close these Pods until the last 2 people leave
Zoe Dunn
Principal
HALE ADVISORS
Dan Gandor
Director, US Customer Experience,
Oncology and Virology
ABBVIE
Lisa Flaiz
Director MCM, Worldwide Digital
Hub Lead for Consumer Marketing
BRISTOL-MYERS SQUIBB
John Lineen
Director, Digital Engagement Lead
(CV/IM), Worldwide Engagement
Planning and Content Capabilities
BRISTOL-MYERS SQUIBB
Janos Penzes
International eMarketing Manager,
Digital Center of Excellence Lead
RICHTER GEDEON
Day 2 - November 10, 2020
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated
VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not
a live chat or faceless group. This is an opportunity to have an engaged conversation
with your industry counterparts. The speaker may have questions for you!
Day 1 - November 9, 2020
Shirley Whitfield
Senior Director, Global Digital
Planning MLR Transformation
ASTRAZENECA
Daphne Earley
Director
VIIV HEALTHCARE
Daphne Earley
Director
VIIV HEALTHCARE
Bharat Tewarie
Member of the Board of Directors
ALVEO TECHNOLOGIES
Former Chief Marketing Officer,
UCB PHARMACEUTICALS
Bharat Tewarie
Member of the Board of Directors
ALVEO TECHNOLOGIES
Former Chief Marketing Officer,
UCB PHARMACEUTICALS
Stephen Ranjan
Vice President, Franchise Lead
Professional and
Non-Insulin Therapy Solutions,
Strategy and Customer Solutions
ROCHE DIABETES CARE
#reimaginepharmahttps://cvent.me/xqEv2r
https://momentumevents.com/re-imaginepharma/
Kate Innelli
Director, Digital Health and Innovation
AMGEN
Kate Innelli
Director, Digital Health and Innovation
AMGEN
Meet the Speaker Pods
12:40 pm
Analyzing The Product Launch Experience During COVID-19
1:00 pm
KEYNOTE PLENARY PRESENTATION
1:20 pm
KEYNOTE PLENARY PRESENTATION
1:40 pm
KEYNOTE PLENARY PRESENTATION
2:00 pm
KEYNOTE PLENARY PRESENTATION
Meet the Speaker Pods
2:20 pm
2:40 pm
Peer Led Offline Conversations
You decide! Official Close of Day 1 - but not the close of discussions.
Speakers will be available for Q&A and further dialogue within their respective
‘Meet The Speaker’ Break Out Pods:
10:00 am
KEYNOTE PLENARY PRESENTATION
10:20 am
KEYNOTE PLENARY PRESENTATION
Broad healthcare industry effects caused by the pandemic (e.g., reduced clinical trial
enrollment, rapid telemed upskilling or adoption for HCPs, patient hesitance to seek
care for new or existing
illness)
Role of digital health in enabling greater access to care during the pandemic
(e.g., telemedicine, at-home screenings, remote trials)
Case study: remote clinical trials for digital tools that can reduce burden for patients
and families/caregivers, paving way for engagement and adherence

4. VIRTUAL SUMMIT
November 9-10, 2020
Francesca Wuttke
Chief Digital Officer
ALMIRALL
Ryan Alovis
CEO
PULSE HEALTH
Virtual Medical Meetings and Meeting the Long Tail For Content Delivery
Panelist:
Alison Woo
Head of Content and Editorial,
Scientific Communications and Innovation
GLAXOSMITHKLINE
Francesca Wuttke
Chief Digital Officer
ALMIRALL
James Musick
Senior Vice President, Global Product
Strategy Head, Personalized Healthcare
GENENTECH/ROCHE
Paul Savidge
US General Counsel
SPARK THERAPEUTICS
Michael Rowbotham
Digital Strategy Lead for Xeljanz
Franchise, Director MCM
PFIZER
Fred Bennett
Head, Patient Strategy and Engagement
INTERCEPT PHARMACEUTICALS
Kevin Hsieh
Service Lead, Web and Mobile
GENENTECH
Jessica Pfennig
Enterprise Digital Leader, Compliance Business Partner,
Commercial Operations NA and Oncology Business Unit
ASTRAZENECA
Day 2 - Novmber 10, 2020
Request 1:1 peer meetings, with video and voice call capabilities to replicate the live
event onsite experience of sharing challenges, solutions and partner evaluations
1:1 AU based matchmaking
Visit Virtual Booths and have live video demonstrations of solutions to navigate
the current uncertainty
Simply exchange thoughts with your peers in interactive networking pods
What Does the New Normal Look Like, and How Can
Pharma Create a Strategic Roadmap for Marketing?
Interactive live polling available to interact with both the experts and attendees!
James Musick
Senior Vice President,
Global Product Strategy Head,
Personalized Healthcare
GENENTECH/ROCHE
Amanda Phraner
Director, Public Relations
and Social Media
HORIZON THERAPEUTICS
Jim Delash
Multichannel Marketing Director
GLAXOSMITHKLINE
Ryan Alovis
CEO
PULSE HEALTH
Alison Woo
Head of Content and Editorial,
Scientific Communications
and Innovation
GLAXOSMITHKLINE
Jamie Rosati
Executive Director, Global Human
Health, Digital Strategy and Enterprise Social Media Group
MERCK
Paul Savidge
US General Counsel
SPARK THERAPEUTICS
Fred Bennett
Head, Patient Strategy
and Engagement
INTERCEPT
PHARMACEUTICALS
Kevin Hsieh
Service Lead, Web and Mobile
GENENTECH
Jessica Pfennig
Enterprise Digital Leader, Compliance
Business Partner, Commercial
Operations NA and Oncology
Business Unit
ASTRAZENECA
#reimaginepharmahttps://cvent.me/xqEv2r
https://momentumevents.com/re-imaginepharma/
10:40 am
Session Outline To Be Determined
11:00 am
Keynote Plenary Presentation
Networking Break
11:20 am
Meet the Speaker Pods
11:40 am
Interactive Roundtable:
Pharma Marketing 2020: the Enduring Impact
12:20 pm
Keynote Plenary Presentation
12:40 pm
Keynote Plenary Presentation
Compliance as a Marketing Business Partner: Maintaining Balance of What
You Could do Before and Now What You Are Limited To Do Due to COVID
1:00 pm
Keynote Plenary Presentation
Meet the Speaker Pods
Paul Murasko
Senior Director, Digital Interaction
IPSEN PHARMACEUTICALS
Michael Rowbotham
Digital Strategy Lead for
Xeljanz Franchise,
Director MCM
PFIZER

5. VIRTUAL SUMMIT
November 9-10, 2020
Day 2 - Novmber 10, 2020
Morris Kimble
Brand Manager,
HCP Marketing - Digital
ELI LILLY
Igor Rudychev
Head of Commercial Analytics
NOVARTIS
Kate Miller
Principal Consultant, Digital
Innovation Practice Lead
EVOLUTION ROAD, LLC
1:40 pm
TRACK A
HCP
TRACK C
ANALYTICS
TRACK D
MEDIA
TRACK B
MARKETING/HEALTH INNOVATION
CASE STUDY Presentation
Virtualization and Industry Dynamics -
How to Wed a Virtualization Approach
to Platforms and Capabilities
CASE STUDY
Session Outline To Be Determined
FIRESIDE CHAT
Adapting to Telehealth in Pharma:
Lessons in Getting Into and Ahead of
the Game
Official Close of Conference
https://www.linkedin.com/groups/101428/
Morris Kimble
Brand Manager,
HCP Marketing - Digital
ELI LILLY
Carmine Attanasio
Associate Director, Digital Product
Marketing, US Hematology
BRISTOL-MYERS SQUIBB
Carmine Attanasio
Associate Director,
Digital Product Marketing,
US Hematology
BRISTOL-MYERS SQUIBB
Igor Rudychev
Head of Commercial Analytics
NOVARTIS
Kate Miller
Principal Consultant,
Digital Innovation Practice Lead
EVOLUTION ROAD, LLC
#reimaginepharmahttps://cvent.me/xqEv2r
https://momentumevents.com/re-imaginepharma/
Thought Leadership Council
2:00 pm
Meet the Speaker Pods
Jeff French,
Vice President and Chief Digital Officer,
VIIV HEALTHCARE
Francesca Wuttke,
Chief Digital Officer,
ALMIRALL
Matt Lasmanis,
Chief Technology Officer and Vice President,
GLAXOSMITHKLINE
James Musick,
Senior Vice President, Global Product Strate-
gy Head, Personalized Healthcare,
GENENTECH/ROCHE
Jamie Rosati
Executive Director, Global Human Health,
Digital Strategy and Enterprise
Social Media Group
MERCK
Paul Murasko,
Senior Director, Digital Interaction,
IPSEN PHARMACEUTICALS
Shwen Gwee,
Vice President and Head of
Global Digital Strategy,
BRISTOL-MYERS SQUIBB
Jim Delash,
Multichannel Marketing Director,
GLAXOSMITHKLINE
Kevin Hsieh,
Service Lead, Web and Mobile,
GENENTECH
Michael Rowbotham,
Digital Strategy Lead for Xeljanz Franchise,
Director MCM,
PFIZER
Alison Woo,
Head of Content and Editorial, Scientific
Communications and Innovation,
GLAXOSMITHKLINE
Kevin Giordano,
Lead External and Product Communications,
SPARK THERAPEUTICS
Lisa Flaiz,
Director MCM, Worldwide Digital Hub
Lead for Consumer Marketing,
BRISTOL-MYERS SQUIBB
Angela Horstmann
Marketing Launch Lead, Immunology
ASTRAZENECA
Driving every event is a simple philosophy: to provide best in class professional deve-
lopment and networking experiences that satisfy the educational and networking
needs of all our clients and event stakeholders. As the field gets perpetually more
crowded, how can today’s smart company rise above the background noise to ensure
that the right people hear your message in the intended capacity? The answer is Mo-
mentum’s thought leadership solutions.
To learn more today, please contact Jayson Mercado at
INTERESTED IN SPONSORING?
mailto:jayson@momentumevents.com